# FDA Inspection 916051 - Sarah Cannon Blood And Marrow Transplant Program Cell Proces - February 27, 2015

Source: https://www.keypedia.com/records/fda_inspections/sarah-cannon-blood-and-marrow-transplant-program-cell-proces/98ebfdce-0dbf-4af9-812a-a50f428cfe4f
Source feed: FDA_Inspections

> FDA Inspection 916051 for Sarah Cannon Blood And Marrow Transplant Program Cell Proces on February 27, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 916051
- Company Name: Sarah Cannon Blood And Marrow Transplant Program Cell Proces
- Inspection Date: 2015-02-27
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 673050 - 2010-07-23](https://www.keypedia.com/records/fda_inspections/sarah-cannon-blood-and-marrow-transplant-program-cell-proces/796b749c-64c2-4762-bd89-9780b569f2b4)
- [FDA Inspection 663729 - 2010-05-25](https://www.keypedia.com/records/fda_inspections/sarah-cannon-blood-and-marrow-transplant-program-cell-proces/c7dbf9e1-06c0-4236-93fc-ca63b3fb7cb6)

Company: https://www.keypedia.com/companies/sarah-cannon-blood-and-marrow-transplant-program-cell-proces/10c81f40-8bee-41af-add2-4c2a675add0b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d